Status:
RECRUITING
Transforming Hemodialysis-Related Vascular Access Education
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
University of North Carolina, Chapel Hill
Johns Hopkins University
Conditions:
Chronic Kidney Disease
Hemodialysis Vascular Access
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for p...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Nephrology visit for chronic kidney disease during the last 18 months
- Most recent eGFR less than or equal to 20 ml/min/1.73 m2 or 2-year Kidney Failure Risk Equation score greater than 40%
- Documentation in the medical record or confirmation from the treating nephrologist of a patient-nephrologist discussion about hemodialysis
Exclusion
- Planning for peritoneal dialysis, preemptive transplant, or conservative management of kidney failure
- Previous placement of an AV access
- Prior appointment with surgeon for AV access evaluation or creation
- Cognitive dysfunction or severe visual impairment that prevents use of the education materials
- Does not speak either English or Spanish
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT05997875
Start Date
December 5 2023
End Date
September 30 2027
Last Update
January 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19106